Social Media Messaging for Colorectal Cancer Screening

Overseen By Andy King, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Utah

Disqualifiers: Colorectal cancer, Non-English speakers, others

Compensation: Varies

Number of Visits: Unknown

2030 Participants Needed

Trial Summary

What is the purpose of this trial?

NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.

Research Team

Andy King, PhD

Principal Investigator

Huntsman Cancer Institute/ University of Utah

Eligibility Criteria

This trial is for adults aged 45 to 74 who self-identify as either White/Caucasian or Black/African American. It aims to gather preferences on cancer screening messages from a national sample, with an equal number of participants from each racial group.

Inclusion Criteria

Identify as white/Caucasian or Black/African American

Exclusion Criteria

Non-English speakers

I have been diagnosed with colorectal cancer before.

Do not identify as white/Caucasian or Black/African American

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Survey Experiment

Participants complete a 15-minute survey after being randomly assigned to one of five conditions

15 minutes

Data Analysis

The study team receives a de-identified data file for analysis after all participants complete the survey

2-4 weeks

Follow-up

Participants are monitored for any additional information sharing behavior and intentions to adhere to screening recommendations

2 weeks

Treatment Details

Interventions

• Social Media and Cancer Screening Information

Trial Overview The study tests the effectiveness of different colorectal cancer screening messages tailored for social media. Participants will evaluate pairs of messages and help identify which ones resonate best within their demographic groups.

Participant Groups

Group I: White American Preferred Experimental Treatment 1 Intervention

Participants in the White American Preferred arm will be shown four White American Preferred messages.

Group II: Overall Preferred Experimental Treatment 1 Intervention

Participants in the Overall Preferred arm will be shown four Overall Preferred messages.

Group III: Median Ranked Experimental Treatment 1 Intervention

Participants in the Median Ranked Arm will be shown four Median Ranked messages.

Group IV: Black American Preferred Experimental Treatment 1 Intervention

Participants in the Black American Preferred arm will be shown four Black American Preferred messages.

Group V: Control (no exposure) Placebo Group 1 Intervention

Participants in the Control Arm will not be shown any messages.

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials

1,169

Recruited

1,623,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+

AmeriSpeak - NORC

Collaborator

Trials

1

Recruited

2,000+